세계 질병 관리 및 예방 백신 시장 : 제품 유형별, 투여 경로별, 적응증별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율(2024-2032년) 예측

REPORT HIGHLIGHT

Disease Control And Prevention Vaccine Market size was valued at USD 51,210.3 Million in 2023, expanding at a CAGR of 10.5% from 2024 to 2032.

Immunization is widely recognized as a significant achievement in public health throughout the twentieth century. Vaccines have proven to be highly effective in preventing diseases, saving lives, and reducing healthcare costs. The widespread adoption of vaccination has successfully prevented disability and death in numerous children, leading governments worldwide to prioritize vaccination in their public health services. China, for instance, has effectively controlled infectious diseases through its national immunization program, which is based on vaccination. The Centers for Disease Control and Prevention (CDC) plays a crucial role in recommending and promoting vaccination programs to protect individuals and communities from vaccine-preventable diseases. The CDC provides vaccination guidelines, monitors vaccine safety, conducts research on vaccine effectiveness, and collaborates with other organizations to ensure a comprehensive approach to disease prevention.

Disease Control And Prevention Vaccine Market- Market Dynamics

Rising incidence of infectious diseases worldwide and the adoption of vaccines are anticipated to propel the expansion of the Disease Control and Prevention Vaccine market.

The global incidence of infectious diseases is on the rise, and the use of vaccines is expected to play a significant role in controlling and preventing their spread. Vaccines are crucial in safeguarding public health, and as awareness about their importance increases, there is a growing adoption of vaccination programs worldwide. Governments, healthcare organizations, and individuals are recognizing the value of vaccines in protecting communities from the burden of infectious diseases. Throughout history, infectious diseases have caused immense suffering, both in terms of illness and death. According to the Center for Disease Control and Prevention, there were 10.2 million visits to physician offices for infectious and parasitic diseases, and 3.8 million emergency department visits with these diseases as the primary diagnosis. Ongoing research and development in vaccine technology hold promising prospects for market growth. However, it is important to note that stringent regulatory processes may pose challenges to the expansion of the Disease Control and Prevention Vaccine market.

Disease Control And Prevention Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2024-2032)

Based on product type segmentation, Live-attenuated Vaccines was predicted to show maximum market share in the year 2023

Based on Route of administration segmentation, Injectable was the leading type in 2023

Based on Indication segmentation, Infectious Disease was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Disease Control And Prevention Vaccine Market- Segmentation Analysis:

The Global Disease Control And Prevention Vaccine Market is segmented on the basis of Product Type, Route of administration, Indication, and Region.

The market is divided into four categories based on product type: Live-attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines and Toxoid Vaccines. Live-attenuated vaccines dominate a substantial portion of the market. Renowned for their remarkable effectiveness, these vaccines closely mimic natural infections, providing robust and long-lasting immunity.

The market is divided into two categories based on Route of administration: Oral and Injectable. The injectable segment commands a substantial portion of the market. Injectable vaccines are delivered through injections, typically either intramuscularly (IM) or subcutaneously (SC), to stimulate the immune system and initiate an immune response.

The market is divided into two categories based on Indication: Infectious Disease, Cancer and Other Indication. The Infectious Disease segment holds significant sway over the market. Many nations implement immunization programs to control the spread of infectious diseases. These programs often include routine childhood vaccinations and targeted vaccinations for specific populations.

Disease Control And Prevention Vaccine Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market growth is expected to be driven by North America in the forecast period, primarily due to the availability of highly advanced technologies and the increasing development of innovative vaccines. North America, especially the United States, is renowned for its advanced healthcare infrastructure and research capabilities. The region is home to numerous pharmaceutical and biotechnology companies that heavily invest in research and development, leading to the development of cutting-edge technologies for vaccine production. By the end of 2022, the United States is projected to spend USD 4.5 trillion on healthcare, making it the country with the highest overall healthcare expenditure globally. According to the latest data and reports on healthcare in the United States, the country's overall spending in 2021 is estimated to reach USD 4.3 trillion, accounting for 18.5% of its GDP. Europe holds the second-largest region for market growth during the forecast period, primarily due to the increasing disease burden.

Disease Control And Prevention Vaccine Market- Competitive Landscape:

The Disease Control and Prevention Vaccine market encompasses a wide range of vaccines developed by various organizations and companies to combat different diseases. Notable contributors to vaccine advancements include the World Health Organization (WHO), National Institutes of Health (NIH), and private entities. The recent emergence of infectious diseases on an unprecedented scale has presented new challenges for vaccine developers, regulators, health authorities, and political constituencies. The manufacturing and distribution of vaccines are complex processes that require both speed and careful consideration of clinical development, emergency use authorization, vaccine safety monitoring, and surveillance of virus variants. It is crucial to prioritize access to vaccines and vaccination efforts in low- and middle-income countries. While the vaccine industry is smaller compared to the pharmaceutical industry, it is steadily growing. Companies within the vaccine industry engage in research, development, manufacturing, sales, marketing, and distribution of vaccines, with their revenue primarily derived from vaccine product sales.

Recent Development:

In October 2023, the FDA has approved PENBRAYA (meningococcal groups A, B, C, W, and Y vaccine), according to Pfizer Inc. This is the first and only pentavalent vaccine that protects against the most common serogroups that cause meningococcal disease in adolescents and young adults (10-25 years of age). In order to help protect against the five most common meningococcal serogroups that cause the majority of invasive meningococcal disease (IMD) worldwide, PENBRAYA combines the components from two meningococcal vaccines: Nimenrix® (meningococcal groups A, C, W-135, and Y conjugate vaccine) and Trumenba® (meningococcal group B vaccine).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Merck & Co. GlaxoSmithKline plc.

Sanofi, AstraZeneca PLC

Pfizer Inc.

Astellas Pharma Inc.

Sinovac Biotech Ltd.

Daiichi Sankyo

Serum Institute of India Pvt. Ltd.

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

• Live-attenuated Vaccines
• Inactivated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

• Oral
• Injectable

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

• Infectious Disease
• Cancer
• Other Indication

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Disease Control And Prevention Vaccine Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Disease Control And Prevention Vaccine Market Snippet by Product Type
  • 2.1.2. Disease Control And Prevention Vaccine Market Snippet by Route of administration
  • 2.1.3. Disease Control And Prevention Vaccine Market Snippet by Indication
  • 2.1.4. Disease Control And Prevention Vaccine Market Snippet by Country
  • 2.1.5. Disease Control And Prevention Vaccine Market Snippet by Region
• 2.2. Competitive Insights

3. Disease Control And Prevention Vaccine Key Market Trends

• 3.1. Disease Control And Prevention Vaccine Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Disease Control And Prevention Vaccine Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Disease Control And Prevention Vaccine Market Opportunities
• 3.4. Disease Control And Prevention Vaccine Market Future Trends

4. Disease Control And Prevention Vaccine Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Disease Control And Prevention Vaccine Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Disease Control And Prevention Vaccine Market Landscape

• 6.1. Disease Control And Prevention Vaccine Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Disease Control And Prevention Vaccine Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
  • 7.1.2. Live-attenuated Vaccines
  • 7.1.3. Inactivated Vaccines
  • 7.1.4. Recombinant Vaccines
  • 7.1.5. Toxoid Vaccines

8. Disease Control And Prevention Vaccine Market - By Route of administration

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Route of administration, 2023 & 2032 (%)
  • 8.1.2. Oral
  • 8.1.3. Injectable

9. Disease Control And Prevention Vaccine Market - By Indication

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
  • 9.1.2. Infectious Disease
  • 9.1.3. Cancer
  • 9.1.4. Other Indication

10. Disease Control And Prevention Vaccine Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Disease Control And Prevention Vaccine Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Disease Control And Prevention Vaccine Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Disease Control And Prevention Vaccine Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Disease Control And Prevention Vaccine Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Disease Control And Prevention Vaccine Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Disease Control And Prevention Vaccine Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Merck & Co. GlaxoSmithKline plc.
  • 11.2.2. Sanofi, AstraZeneca PLC
  • 11.2.3. Pfizer Inc.
  • 11.2.4. Astellas Pharma Inc.
  • 11.2.5. Sinovac Biotech Ltd.
  • 11.2.6. Daiichi Sankyo
  • 11.2.7. Serum Institute of India Pvt. Ltd.

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us